News

Probiotic Study Shows Promise on Improving Innate Immunity

BIO-CAT, Inc,  | BIO-CAT announced that a newly published study on the probiotic Bacillus subtilis MB40 revealed promising results leading to the reduction of Listeria. The study was designed to determine the effects of Bacillus subtilis MB40 supplementation on innate immunity and Listeria. This study was completed in partnership with the School of Animal Sciences at Virginia Tech in Blacksburg, Virginia.

Increasingly mentioned in the news, Listeria can cause life threatening infections. While Listeria is sensitive to antibiotics such as penicillin and ampicillin, BIO-CAT sought to understand whether the presence of Listeria could be reduced with probiotic supplementation alone.

Dr. Jessica Spears, Director of Research and Development for Probiotics at BIO-CAT Microbials in Shakopee, Minnesota, says “The continued science on Bacillus strains – not just in humans but also in animals, further supports that spores should be high on the list when considering new probiotic applications. It was encouraging to see that the inclusion of Bacillus subtilis MB40 spores in the diet helped improve innate immunity.”

In addition to reducing Listeria in this study, Bacillus subtilis MB40 has also proven successful against Staphylococcus aureus colonization in humans, as a study conducted by the National Institutes of Health recently reported.

Bacillus subtilis MB40 is currently sold by Kerry Group of Ireland under the name Sporevia™.

BIO-CAT Microbials was acquired in 2004 by BIO-CAT Inc., an enzyme industry leader located in Troy, Virginia. For 17 years, BIO-CAT Microbials has focused on three core life science verticals: human, animal, and crop nutrition. BIO-CAT Microbials continues to be an innovative global biotech leader that supports customers with advanced microbial solutions. As industry experts, their science-led team specializes in strain development, fermentation, and product development.

Recent News

04/24/2025

SSI Diagnostica Group Acquires Breath Test Maker Gulf Coast Scientific

Infectious disease diagnostics firm SSI Diagnostica Group said on Thursday that it has acquired Florida-based breath testing firm Gulf Coast Scientific for an undisclosed sum. Gulf Coast Scientific is a developer of urea breath tests for Helicobacter pylori infection, which is associated with conditions including chronic gastritis and gastric cancer. SSID Group said that the

04/23/2025

Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova’s board, and the successful completion of a new round of growth equity capital. These developments support Grenova’s strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories

04/22/2025

Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System, Ushering in a New Era of Modern Medicine Manufacturing in America

Phlow Corp., a leading pharmaceutical contract development and manufacturing organization (CDMO) in America, announced a significant expansion in its analytical capabilities, use of artificial intelligence (AI), workforce, and domestic infrastructure. Marking a period of exceptional growth and momentum, Phlow has more than doubled in size and now employs over 90+ highly skilled scientists and professionals